Efficacy and Safety of E7777 (improved purity Denileukin diftitox [ONTAK]) in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma: Results from Pivotal Study 302 Foss, F. M., Kim, Y. H., Prince, H., Kuzel, T. M., Yannakou, C. K., Ooi, C., Xing, D., Sauter, N., Singh, P., Czuczman, M., Duvic, M. AMER SOC HEMATOLOGY. 2022: 1491-1492

View details for DOI 10.1182/blood-2022-166916

View details for Web of Science ID 000893223201204